Table 3.
Variables | Event-Free Survival | Overall Survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
Univariate Analysis | ||||||
FXIII-A expression pattern | ||||||
FXIII-A negative | 0.66 | 0.29–1.51 | 0.323 | 0.80 | 0.28–2.24 | 0.665 |
FXIII-A bright | 1.52 | 0.66–3.47 | 1.26 | 0.45–3.54 | ||
Age | ||||||
1–5 years | 0.52 | 0.24–1.17 | 0.116 | 0.36 | 0.13–1.02 | 0.056 |
≥6 years | 1.90 | 0.85–4.24 | 2.75 | 0.98–7.72 | ||
WBC | ||||||
<20,000 | 0.49 | 0.21–1.13 | 0.093 | 0.68 | 0.23–1.98 | 0.477 |
≥ 20,000 | 2.06 | 0.89–4.76 | 1.48 | 0.50–4.32 | ||
Sex | ||||||
Male | 1.21 | 0.53–2.78 | 0.647 | 1.43 | 0.49–4.17 | 0.518 |
Female | 0.82 | 0.36–1.89 | 0.70 | 0.24–2.05 | ||
prednisone response | ||||||
PGR | 0.36 | 0.13–0.96 | 0.041 | 0.28 | 0.09–0.87 | 0.028 |
PPR | 2.81 | 1.04–7.58 | 3.61 | 1.15–11.35 | ||
FC risk categories | ||||||
FLR/FMR | 2.48 | 0.72–8.56 | 0.150 | 1.90 | 0.41–8.80 | 0.411 |
FLR/FHR | 3.29 | 0.77–13.9 | 0.106 | 3.53 | 0.65–19.28 | 0.145 |
ALLIC BFM 2009 classification | ||||||
BFM-HR/BFM-SR | 0.21 | 0.05–0.97 | 0.045 | 0.15 | 0.02–1.22 | 0.076 |
BFM-HR/BFM-IR | 0.47 | 0.20–1.11 | 0.085 | 0.37 | 0.13–1.04 | 0.060 |
Genetic risk categories | ||||||
good/intermediate | 2.14 | 0.89–5.17 | 0.091 | 2.50 | 0.75–8.30 | 0.135 |
good/high | 6.48 | 1.69–24.84 | 0.006 | 10.5 | 2.33–47.2 | 0.002 |
B-other | ||||||
Recurrent genetic abnormalities | 0.61 | 0.27–1.36 | 0.228 | 0.66 | 0.24–1.81 | 0.413 |
B-other | 1.64 | 0.73–3.67 | 1.53 | 0.55–4.21 | ||
Multivariate Analysis | ||||||
FXIII-A bright | 0.54 | 0.22–1.34 | 0.108 | 0.59 | 0.19–1.88 | 0.3751 |
Genetic risk categories | ||||||
good/intermediate | 2.33 | 0.87–6.22 | 0.091 | 2.63 | 0.68–10.25 | 0.164 |
good/high | 4.55 | 1.14–18.15 | 0.032 | 7.44 | 1.54–36.00 | 0.013 |
p < 0.05 values were considered statistically significant, such p values are marked in bold.